The Takeda Pharmaceutical Co-led group that is developing a blood plasma treatment for COVID-19 has started manufacturing while the late-stage trial to determine whether...
No serious adverse effects detected during Sputnik M trials, Health Ministry says.
Clinical trials of the Sputnik M vaccine against coronavirus for teens aged 12-17...
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), R-Pharm group and AstraZeneca announce interim results of phase II clinical trials to evaluate...